Photo taken from Thomas Powles/X
Jan 31, 2024, 15:42
Thomas Powles: We need better biomarkers in Urothelial Carcinoma
Thomas Powles, Director of Barts Cancer Centre, shared a post on X/Twitter:
“Microsatellite instability (MSIH) is linked to miss match repair deficiency and is used in endometrial cancer for response to Immuno-Oncology (I-O). In Urothelial Carcinoma (UC), it is associated with an increase in Tumor Mutational Burden (TMB) and Progression-free survival (PFS) (but only 2% of tumors). This doesn’t seem to solve our problems. We need better biomarkers in UC.”
Source: Thomas Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 15:28
Dec 2, 2024, 15:25
Dec 2, 2024, 13:53